Translational Development of a Silk-Elastinlike Protein Polymer Embolic for Transcatheter Arterial Embolization.
Translational Development of a Silk-Elastinlike Protein Polymer Embolic for Transcatheter Arterial Embolization.
复制标题
DOI:
10.1002/mabi.202100401
复制
发表时间:
2022-03
影响因子:
4.6
通讯作者:
Ghandehari, Hamidreza
中科院分区:
文献类型:
--
作者:
Hatlevik, Oyvind;Jensen, Martin;Steinhauff, Douglas;Wei, Xiaomei;Huo, Eugene;Jedrzkiewicz, Jolanta;Cappello, Joseph;Cheney, Darwin;Ghandehari, Hamidreza
Locally blocking blood flow to tumors with embolic materials is key to transcatheter arterial embolization for treating hepatocellular carcinoma. Current microparticle agents do not deeply penetrate target tissues and are compatible with a very limited selection of therapeutic agents. Silk-elastinlike protein polymers (SELPs) combine the solubility of elastin and the strength of silk to create an easily injected liquid embolic that transitions into a solid depot amenable to loading with drugs, gene therapy agents, or biologics. SELP, injected as liquid solution, penetrates the vasculature before transitioning to a solid hydrogel. The objective of this manuscript was to evaluate SELP embolization, stability, and biocompatibility at 7-, 30-, and 90-day survival intervals in a porcine model. SELP embolics selectively block blood flow in the kidneys and livers, with no off-target infarctions. As assessed with angiography, SELP renal embolization exhibited decreasing persistence for the duration of the 90-day study period. There was an increased presence of microscopic SELP emboli in the renal setting, compared to Embosphere®. Histologically scored inflammatory reactions to SELP are decreased in both the renal and hepatic implantations compared to Embosphere®. In conclusion, a bioresorbable SELP liquid embolic system deeply penetrates target tissue and selectively embolizes blood vessels in vivo. A liquid silk-elastinlike protein-based polymer (SELP) embolic is compared to a clinical microsphere, Embosphere®, for embolic applications in porcine renal and hepatic settings. SELP is capable of comparable or improved embolization with regards to Embosphere®. The liquid SELP embolic produces reduced inflammatory responses compared to Embosphere®, with no long-term health concerns over the 90-day study period.
登录
查看更多内容
影响因子:
2.9
作者:
Dreher, Matthew R.;Sharma, Karun V.;Woods, David L.;Reddy, Goutham;Tang, Yiqing;Pritchard, William F.;Chiesa, Oscar A.;Karanian, John W.;Esparza, Juan A.;Donahue, Danielle;Levy, Elliot B.;Willis, Sean L.;Lewis, Andrew L.;Wood, Bradford J.
通讯作者:
Wood, Bradford J.
影响因子:
3.7
作者:
Hatefi, A.;Cappello, J.;Ghandehari, H.
通讯作者:
Ghandehari, H.
影响因子:
4.9
作者:
Poursaid, Azadeh;Jensen, Mark Martin;Ghandehari, Hamidreza
通讯作者:
Ghandehari, Hamidreza
影响因子:
4.9
作者:
Cresce, Arthur von Wald;Dandu, Ramesh;Ghandehari, Hamidreza
通讯作者:
Ghandehari, Hamidreza
影响因子:
3.8
作者:
Miksad, Rebecca A.;Ogasawara, Sadahisa;Piscaglia, Fabio
通讯作者:
Piscaglia, Fabio